Literature DB >> 8706198

Clinical comparison of sevoflurane and isoflurane when administered with nitrous oxide for surgical procedures of intermediate duration.

C Campbell1, M L Nahrwold, D D Miller.   

Abstract

The purpose of this study was to compare the haemodynamic effects and emergence times of anaesthesia with sevoflurane with those of isoflurane when the agents were administered with nitrous oxide to adult patients (ASA I and II) undergoing surgery of at least an hour in duration. Fifty patients were randomly assigned to receive either 0.65 minimum alveolar concentration (MAC) (1.3%) sevoflurane or 0.65 MAC (0.8%) isoflurane together with 60% nitrous oxide following induction with thiopentone, fentanyl, and succinylcholine. Systemic blood pressure and heart rate trends were similar for both groups for the duration of anaesthesia. However, differences in systolic blood pressure measurements were noted at one minute after incision (99 +/- 3 mmHg, mean +/- SE, in the sevoflurane group compared with 109 +/- 4 mmHg for isoflurane), and at emergence (125 +/- 3 mmHg for sevoflurane, 134 +/- 3 mmHg for isoflurane), and in diastolic blood pressure measurements at five minutes after intubation (64 +/- 2 mmHg for sevoflurane, 73 +/- 3 mmHg for isoflurane). Recovery of response to command was more rapid after discontinuation of sevoflurane-nitrous oxide (9.9 +/- 1.1 min) than after isoflurane-nitrous oxide (13.9 +/- 1.3 min). Despite earlier emergence, patients who had received sevoflurane did not request postoperative analgesia sooner. We conclude that the purported advantages of sevoflurane, namely haemodynamic stability and rapid emergence, can be expected even when the agent is administered at 0.65 MAC (1.3%) in nitrous oxide to a typical adult surgical population undergoing procedures of intermediate duration (2.3 +/- 0.2 hr).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8706198     DOI: 10.1007/BF03011036

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  16 in total

1.  The safety of sevoflurane in humans.

Authors:  R I Mazze
Journal:  Anesthesiology       Date:  1992-12       Impact factor: 7.892

2.  Comparison of kinetics of sevoflurane and isoflurane in humans.

Authors:  N Yasuda; S H Lockhart; E I Eger; R B Weiskopf; J Liu; M Laster; S Taheri; N A Peterson
Journal:  Anesth Analg       Date:  1991-03       Impact factor: 5.108

3.  Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues.

Authors:  N Yasuda; A G Targ; E I Eger
Journal:  Anesth Analg       Date:  1989-09       Impact factor: 5.108

4.  Influence of age on awakening concentrations of sevoflurane and isoflurane.

Authors:  T Katoh; Y Suguro; T Ikeda; T Kazama; K Ikeda
Journal:  Anesth Analg       Date:  1993-02       Impact factor: 5.108

5.  Sevoflurane: a new inhalational anesthetic agent.

Authors:  R F Wallin; B M Regan; M D Napoli; I J Stern
Journal:  Anesth Analg       Date:  1975 Nov-Dec       Impact factor: 5.108

6.  Haemodynamic and organ blood flow responses to sevoflurane during spontaneous ventilation in the rat: a dose-response study.

Authors:  M W Crawford; J Lerman; M Pilato; H Orrego; V Saldivia; F J Carmichael
Journal:  Can J Anaesth       Date:  1992-03       Impact factor: 5.063

7.  Sevoflurane anaesthesia for major intra-abdominal surgery.

Authors:  A C Quinn; P J Newman; G M Hall; R M Grounds
Journal:  Anaesthesia       Date:  1994-07       Impact factor: 6.955

8.  Comparison of induction, maintenance, and recovery characteristics of sevoflurane-N2O and propofol-sevoflurane-N2O with propofol-isoflurane-N2O anesthesia.

Authors:  I Smith; Y Ding; P F White
Journal:  Anesth Analg       Date:  1992-02       Impact factor: 5.108

9.  Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers.

Authors:  D A Holaday; F R Smith
Journal:  Anesthesiology       Date:  1981-02       Impact factor: 7.892

10.  Humans anesthetized with sevoflurane or isoflurane have similar arrhythmic response to epinephrine.

Authors:  R Navarro; R B Weiskopf; M A Moore; S Lockhart; E I Eger; D Koblin; G Lu; C Wilson
Journal:  Anesthesiology       Date:  1994-03       Impact factor: 7.892

View more
  3 in total

Review 1.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

Review 2.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

3.  Effect of charcoal filter on the emergence from sevoflurane anesthesia in a semi-closed rebreathing circuit.

Authors:  Dong Jin Chang; Seung Ho Choi; Yong Suk Choi; Kyeong Tae Min
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.